FDA Issues Warning and Recall for Stryker Hip Implant

Aug. 27, 2012

According to a US Food and Drug Administration (FDA) press release, medical device manufacturer Stryker Orthopedics recently issued a voluntary recall of its Rejuvenate modular and ABG-II modular-neck hip stem implants due to risks caused by deterioration of the device.

In July, Stryker issued a statement saying that the devices would be recalled due to corrosion and fretting that can develop over time. The metal stem of the device rubs against the metal neck when movement occurs, which can cause small pieces of metal to wear off over time resulting in hip irritation and swelling.

A patient who is affected by the Arkansas hip implant injury could also develop a condition known as Metallosis, where small metal particles that have rubbed off of the device are absorbed into the blood stream. The condition is known to cause patients to suffer from:

–          Tissue Damage

–          Pain

–          Pseudo-Tumors

–          Bone Damage

–          Failure of the hip joint

The recall went on to say that patients with the device implanted should consult their surgeons immediately if they experience any pain or swelling around the location of the implant.

It was announced last week that lawsuits have already been filed in connection to injuries associated with the Stryker Hip Implant Recall.

The Arkansas Personal Injury Lawyers with Rainwater, Holt & Sexton would urge anyone who has suffered due to a defective hip implant to contact an experienced attorney immediately.